Medtronic (NYSE:MDT) today announced new milestones for its Affera family of technologies, including FDA breakthrough device ...

A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.

Medtech company Medtronic has completed its $585 million acquisition of CathWorks, an interventional cardiology medical device company.  The deal follows a 2022 strategic partnership between the ...

Spine surgeons have begun performing the first cases using Medtronic’s new robotic technology. Jeffrey Gum, MD, performed the world’s first case using Medtronic’s Stealth AXiS spine robot, according ...

New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault ...

Years after being absorbed by Medtronic, Northridge-based MiniMed Group has spun off on its own again and went through an IPO. Chief Executive Que Dallara at the ribbon cutting ceremony for MiniMed in ...

'Mad Money' host Jim Cramer digs into the recent stock performance of Medtronic. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your ...

MiniMed Group (MMED) lost ~5% as Medtronic’s (MDT) diabetes business began trading as a public company on Thursday following its separation from the parent via an IPO that raised $560M for the insulin ...

March 5 (Reuters) - MiniMed, the diabetes business of medical device maker Medtronic (MDT.N), opens new tab, said on Thursday it has raised $560 million in its U.S. initial public offering. The ...

Feb 24 (Reuters) - Medtronic's (MDT.N), opens new tab MiniMed Group said on Tuesday it was targeting up to $7.86 billion valuation in its U.S. initial public offering, marking a step forward in the ...

Neuroscience Portfolio revenue of $2.558 billion, an increase of 4.1% reported and 2.5% organic, with a mid-single digit increase in Neuromodulation, a mid-single digit increase in Cranial & Spinal ...

Medtronic (MDT) lost ~5% in the premarket on Tuesday after the MedTech giant released its Q3 results for fiscal 2026, reaffirming its full-year earnings outlook that was in line with Street forecasts ...